Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network
- PMID: 29942495
- PMCID: PMC6007332
- DOI: 10.1093/ckj/sfx122
Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network
Abstract
In kidney transplant recipients, cancer is one of the leading causes of death with a functioning graft beyond the first year of kidney transplantation, and malignancies account for 8-10% of all deaths in the USA (2.6 deaths/1000 patient-years) and exceed 30% of deaths in Australia (5/1000 patient-years) in kidney transplant recipients. Patient-, transplant- and medication-related factors contribute to the increased cancer risk following kidney transplantation. While it is well established that the overall immunosuppressive dose is associated with an increased risk for cancer following transplantation, the contributive effect of different immunosuppressive agents is not well established. In this review we will discuss the different risk factors for malignancies after kidney transplantation.
Keywords: immunosuppression; kidney transplantation; malignancy; risk factor.
Figures
Similar articles
-
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.Cochrane Database Syst Rev. 2019 Dec 16;12(12):CD004290. doi: 10.1002/14651858.CD004290.pub3. Cochrane Database Syst Rev. 2019. PMID: 31840244 Free PMC article.
-
Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience.Neoplasma. 2017;64(2):311-317. doi: 10.4149/neo_2017_220. Neoplasma. 2017. PMID: 28052685
-
Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.Drugs. 2009 Nov 12;69(16):2227-43. doi: 10.2165/11319260-000000000-00000. Drugs. 2009. PMID: 19852526 Review.
-
Malignancies in adult kidney transplant candidates and recipients: current status.Nephrol Dial Transplant. 2023 Jun 30;38(7):1591-1602. doi: 10.1093/ndt/gfac239. Nephrol Dial Transplant. 2023. PMID: 35998321
-
Malignancies after pediatric kidney transplantation: more than PTLD?Pediatr Nephrol. 2014 Sep;29(9):1517-28. doi: 10.1007/s00467-013-2622-5. Epub 2013 Sep 24. Pediatr Nephrol. 2014. PMID: 24061645 Review.
Cited by
-
Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients.Clin Kidney J. 2024 Mar 9;17(4):sfae061. doi: 10.1093/ckj/sfae061. eCollection 2024 Apr. Clin Kidney J. 2024. PMID: 38606169 Free PMC article. Review.
-
Malignancies after pediatric solid organ transplantation.Pediatr Nephrol. 2021 Aug;36(8):2279-2291. doi: 10.1007/s00467-020-04790-2. Epub 2020 Oct 15. Pediatr Nephrol. 2021. PMID: 33057766
-
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.Dermatol Ther (Heidelb). 2023 Apr;13(4):867-889. doi: 10.1007/s13555-023-00905-3. Epub 2023 Mar 16. Dermatol Ther (Heidelb). 2023. PMID: 36929121 Free PMC article.
-
Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hosts.J Immunother Cancer. 2023 Sep;11(9):e006783. doi: 10.1136/jitc-2023-006783. J Immunother Cancer. 2023. PMID: 37678918 Free PMC article.
-
Diagnosis of urothelial carcinoma of the primary kidney allograft using a multi-diagnostic approach: A case report.Radiol Case Rep. 2025 Jun 14;20(9):4390-4393. doi: 10.1016/j.radcr.2025.05.065. eCollection 2025 Sep. Radiol Case Rep. 2025. PMID: 40583978 Free PMC article.
References
-
- Pilmore H, Dent H, Chang S. et al. Reduction in cardiovascular death after kidney transplantation. Transplantation 2010; 89: 851–857 - PubMed
-
- Collins AJ, Foley RN, Chavers B. et al. United States Renal Data System 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012; 59: e1–e420 - PubMed
-
- Grulich AE, van Leeuwen MT, Falster MO. et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59–67 - PubMed
-
- Kiberd BA, Rose C, Gill JS.. Cancer mortality in kidney transplantation. Am J Transplant 2009; 9: 1868–1875 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources